A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
Fashion giant Michael Kors Holdings announces that it is phasing out real fur over the next year.
The little boy cried for help but began making the two-mile journey home on his own when there was no response.
With more people in the UK living in temporary accommodation, parts of England will soon trial a scheme which has tackled the problem.